| Dr Loyd S Godwin, MD | |
|
4 Corporate Dr., Suite 386, Shelton, CT 00648 | |
| (203) 538-5682 | |
| (203) 538-5685 |
| Full Name | Dr Loyd S Godwin |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 26 Years |
| Location | 4 Corporate Dr., Shelton, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952378127 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 040226 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Connecticut Skinhealth Llp | 9638309362 | 28 |
News Archive
The University of Massachusetts Amherst recently licensed a new technology to Janssen Pharmaceuticals, Inc. that holds promise of revolutionizing the treatment of cataracts and presbyopia, based on early phase discoveries by polymer physicist Murugappan Muthukumar and former graduate student Ben Mohr regarding the fundamental science of proteins in the lens of the human eye.
NeuroSigma, Inc., a California-based medical device company, today announced the launch of www.monarch-etns.com, its dedicated website for the Monarch™ eTNSTM System.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.
The now classic lab manual Antibodies, by Harlow and Lane, has been revised, extended, and updated by Edward Greenfield of the Dana-Farber Cancer Center, with contributions from other leaders in the field.
› Verified 8 days ago
| Entity Name | Connecticut Skinhealth Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649606385 PECOS PAC ID: 9638309362 Enrollment ID: O20140225001960 |
News Archive
The University of Massachusetts Amherst recently licensed a new technology to Janssen Pharmaceuticals, Inc. that holds promise of revolutionizing the treatment of cataracts and presbyopia, based on early phase discoveries by polymer physicist Murugappan Muthukumar and former graduate student Ben Mohr regarding the fundamental science of proteins in the lens of the human eye.
NeuroSigma, Inc., a California-based medical device company, today announced the launch of www.monarch-etns.com, its dedicated website for the Monarch™ eTNSTM System.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.
The now classic lab manual Antibodies, by Harlow and Lane, has been revised, extended, and updated by Edward Greenfield of the Dana-Farber Cancer Center, with contributions from other leaders in the field.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Loyd S Godwin, MD 4 Corporate Dr., Suite 386, Shelton, CT 06484 Ph: (203) 538-5682 | Dr Loyd S Godwin, MD 4 Corporate Dr., Suite 386, Shelton, CT 00648 Ph: (203) 538-5682 |
News Archive
The University of Massachusetts Amherst recently licensed a new technology to Janssen Pharmaceuticals, Inc. that holds promise of revolutionizing the treatment of cataracts and presbyopia, based on early phase discoveries by polymer physicist Murugappan Muthukumar and former graduate student Ben Mohr regarding the fundamental science of proteins in the lens of the human eye.
NeuroSigma, Inc., a California-based medical device company, today announced the launch of www.monarch-etns.com, its dedicated website for the Monarch™ eTNSTM System.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.
The now classic lab manual Antibodies, by Harlow and Lane, has been revised, extended, and updated by Edward Greenfield of the Dana-Farber Cancer Center, with contributions from other leaders in the field.
› Verified 8 days ago
Dr. Heather K Hamilton, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr Ste 386, Shelton, CT 06484 Phone: 203-538-5682 Fax: 203-538-5685 | |
Dr. Grace Dolores Bandow, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr, Shelton, CT 06484 Phone: 203-538-5682 | |
Dr. Katherine Thompson Burke, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr Ste 386, Shelton, CT 06484 Phone: 203-538-5682 |